These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 15098007)

  • 1. Application of SELDI-TOF mass spectrometry for the identification of differentially expressed proteins in transformed follicular lymphoma.
    Lin Z; Jenson SD; Lim MS; Elenitoba-Johnson KS
    Mod Pathol; 2004 Jun; 17(6):670-8. PubMed ID: 15098007
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of protein biomarkers in Dupuytren's contracture using surface enhanced laser desorption ionization time-of-flight mass spectrometry (SELDI-TOF-MS).
    O'Gorman D; Howard JC; Varallo VM; Cadieux P; Bowley E; McLean K; Pak BJ; Gan BS
    Clin Invest Med; 2006 Jun; 29(3):136-45. PubMed ID: 17058431
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Primary cutaneous follicular lymphoma: an assessment of clinical, histopathologic, immunophenotypic, and molecular features.
    Mirza I; Macpherson N; Paproski S; Gascoyne RD; Yang B; Finn WG; Hsi ED
    J Clin Oncol; 2002 Feb; 20(3):647-55. PubMed ID: 11821444
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cutaneous b-cell lymphomas of follicular and marginal zone types: use of Bcl-6, CD10, Bcl-2, and CD21 in differential diagnosis and classification.
    de Leval L; Harris NL; Longtine J; Ferry JA; Duncan LM
    Am J Surg Pathol; 2001 Jun; 25(6):732-41. PubMed ID: 11395550
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Grading of follicular lymphoma: comparison of routine histology with immunohistochemistry.
    Martinez AE; Lin L; Dunphy CH
    Arch Pathol Lab Med; 2007 Jul; 131(7):1084-8. PubMed ID: 17616995
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cutaneous presentation of follicular lymphomas.
    Franco R; Fernández-Vázquez A; Mollejo M; Cruz MA; Camacho FI; García JF; Navarrete M; Piris MA
    Mod Pathol; 2001 Sep; 14(9):913-9. PubMed ID: 11557789
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quality control and quality assessment of data from surface-enhanced laser desorption/ionization (SELDI) time-of flight (TOF) mass spectrometry (MS).
    Hong H; Dragan Y; Epstein J; Teitel C; Chen B; Xie Q; Fang H; Shi L; Perkins R; Tong W
    BMC Bioinformatics; 2005 Jul; 6 Suppl 2(Suppl 2):S5. PubMed ID: 16026602
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of complex autoantibody repertoires by surface-enhanced laser desorption/ionization-time of flight mass spectrometry.
    Grus FH; Joachim SC; Pfeiffer N
    Proteomics; 2003 Jun; 3(6):957-61. PubMed ID: 12833520
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proteomic analysis of dunning prostate cancer cell lines with variable metastatic potential using SELDI-TOF.
    Gretzer MB; Chan DW; van Rootselaar CL; Rosenzweig JM; Dalrymple S; Mangold LA; Partin AW; Veltri RW
    Prostate; 2004 Sep; 60(4):325-31. PubMed ID: 15264244
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SELDI-TOF-MS ProteinChip array profiling of tears from patients with dry eye.
    Grus FH; Podust VN; Bruns K; Lackner K; Fu S; Dalmasso EA; Wirthlin A; Pfeiffer N
    Invest Ophthalmol Vis Sci; 2005 Mar; 46(3):863-76. PubMed ID: 15728542
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of ProteinChip array surface enhanced laser desorption/ionization time-of-flight mass spectrometry (SELDI-TOF MS) to identify thymosin beta-4, a differentially secreted protein from lymphoblastoid cell lines.
    Diamond DL; Zhang Y; Gaiger A; Smithgall M; Vedvick TS; Carter D
    J Am Soc Mass Spectrom; 2003 Jul; 14(7):760-5. PubMed ID: 12837598
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recent advancements in surface-enhanced laser desorption/ionization-time of flight-mass spectrometry.
    Merchant M; Weinberger SR
    Electrophoresis; 2000 Apr; 21(6):1164-77. PubMed ID: 10786889
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of ligand binding by bioaffinity mass spectrometry.
    Zhu Y; Valdes R; Simmons CQ; Linder MW; Pugia MJ; Jortani SA
    Clin Chim Acta; 2006 Sep; 371(1-2):71-8. PubMed ID: 16624266
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Screening of differentially expressed proteins associated with directional highly lymphatic metastasis in ovarian carcinoma cell lines using SELDI-TOF-MS technology].
    Guan X; Li DR; Wang Q; Li L; Ruan HY; Zhang W
    Ai Zheng; 2008 Nov; 27(11):1155-60. PubMed ID: 19000445
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Complex diagnosis of follicular lymphomas].
    Tóth E; Schneider T; Melegh Z; Csernák E; Udvarhelyi N; Rosta A; Szentirmay Z
    Magy Onkol; 2005; 49(2):135-40. PubMed ID: 16249809
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SELDI-TOF MS proteinchip technology for screening of serum markers of HBV-induced hepatocellular carcinoma.
    Geng X; Wang F; Li YG; Zhu GP; Zhang WM
    J Exp Clin Cancer Res; 2007 Dec; 26(4):505-8. PubMed ID: 18365545
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of surface enhanced laser desorption/ionization-time of flight mass spectrometry (SELDI-TOF MS) to study protein expression in a rat model of cocaine withdrawal.
    Geng T; Seitz PK; Thomas ML; Xu B; Soman KV; Kurosky A; Luxon BA; Cunningham KA
    J Neurosci Methods; 2006 Nov; 158(1):1-12. PubMed ID: 16766040
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Surface-enhanced laser desorption ionization time-of-flight mass spectrometry (SELDI TOF-MS) and ProteinChip technology in proteomics research.
    Seibert V; Wiesner A; Buschmann T; Meuer J
    Pathol Res Pract; 2004; 200(2):83-94. PubMed ID: 15237917
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of Human Proteome Organization Plasma Proteome Project (HUPO PPP) reference specimens using surface enhanced laser desorption/ionization-time of flight (SELDI-TOF) mass spectrometry: multi-institution correlation of spectra and identification of biomarkers.
    Rai AJ; Stemmer PM; Zhang Z; Adam BL; Morgan WT; Caffrey RE; Podust VN; Patel M; Lim LY; Shipulina NV; Chan DW; Semmes OJ; Leung HC
    Proteomics; 2005 Aug; 5(13):3467-74. PubMed ID: 16052624
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An immunophenotypic and molecular study of primary large B-cell lymphoma of bone.
    Huebner-Chan D; Fernandes B; Yang G; Lim MS
    Mod Pathol; 2001 Oct; 14(10):1000-7. PubMed ID: 11598170
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.